Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

498.48
-1.8700-0.37%
Post-market: 498.480.00000.00%16:04 EDT
Volume:464.24K
Turnover:232.54M
Market Cap:21.38B
PE:17.84
High:505.78
Open:500.62
Low:497.67
Close:500.35
52wk High:609.35
52wk Low:397.00
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.59
T/O Rate:1.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.34
PE(LYR):17.89

Loading ...

United Therapeutics Chairperson, CEO Martine Rothblatt Disposes of 9,500 Common Shares for $5.12 Million

Reuters
·
Jun 30

United Therapeutics Shareholders Approve 2026 Stock Incentive Plan at Annual Meeting

Reuters
·
Jun 30

United Therapeutics Wins FDA Approval for Lungfx Lung Perfusion Device

Reuters
·
Jun 29

United Therapeutics Corp - Lung Bioengineering Expects to Add Lungfx to Services in 2027

THOMSON REUTERS
·
Jun 29

United Therapeutics Corporation Announces FDA Approval of the Lungfx™ Device for Centralized Ex Vivo Lung Perfusion

THOMSON REUTERS
·
Jun 29

United Therapeutics CEO Martine Rothblatt Disposes of USD 4.99 Million in Common Shares

Reuters
·
Jun 26

United Therapeutics Chairperson and CEO Martine Rothblatt Disposes of Common Shares Worth $5.08 Million

Reuters
·
Jun 24

United Therapeutics CFO James Edgemond sells 8,750 shares worth $4.7 million

Reuters
·
Jun 24

United Therapeutics CEO Martine Rothblatt disposes of 11,480 common shares worth $6.19 million

Reuters
·
Jun 23

United Therapeutics Chairperson, CEO Martine Rothblatt disposes of USD 5.19 million in common shares

Reuters
·
Jun 18

United Therapeutics CFO, Treasurer James Edgemond disposes of USD 9.12 million in common shares

Reuters
·
Jun 17

United Therapeutics Chairperson, CEO Martine Rothblatt sells $4.9 million in common shares

Reuters
·
Jun 16

United Therapeutics CFO James Edgemond disposes of common shares worth $5.42 million

Reuters
·
Jun 13

United Therapeutics Chairperson, CEO Martine Rothblatt disposes of common shares worth $5.17 million

Reuters
·
Jun 13

Analysts Conflicted on These Healthcare Names: United Therapeutics (UTHR), DENTSPLY SIRONA (XRAY) and Climb Bio (CLYM)

TIPRANKS
·
Jun 12

United Therapeutics Chairperson, CEO Martine Rothblatt reports disposal of 8,500 common shares worth $4.65 million

Reuters
·
Jun 12

United Therapeutics CFO James Edgemond disposes of USD 5.47 million in common shares

Reuters
·
Jun 10

United Therapeutics CEO Chairperson Martine Rothblatt disposes of common shares worth $5.2 million

Reuters
·
Jun 10

United Therapeutics CEO Martine Rothblatt disposes of common shares worth $5.19 million

Reuters
·
Jun 09

United Therapeutics CFO James Edgemond disposes of 8,000 shares worth $4.36 million

Reuters
·
Jun 06